The following administrative revisions have been made to the New Protocol Checklist (N):

• Question 28b has been revised to request additional information about whether the research will involve the National Institutes of Health (NIH) Genome Wide Association Studies (GWAS) Program.
• Questions 29 regarding use of investigational drug has been revised to confirm if UHCMC Investigational Drug Services (IDS) is to be utilized as part of the study and to request a copy of the IDS Exemption Request Form.
• Question 29 has also been revised to request a copy of the IND/IDE correspondence affirming IND/IDE status from either the FDA or the Study Sponsor.
• Question 35 has been revised to correct the name of the Dahms Clinical research Unit (DCRU).